PF-06282999 Uses, Dosage, Side Effects and more
Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
| Trade Name | PF-06282999 |
| Generic | PF-06282999 |
| Type | |
| Formula | C13H12ClN3O3S |
| Weight | Average: 325.77 Monoisotopic: 325.0287901 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
